Sara E. Kost

1.5k total citations
14 papers, 1.2k citations indexed

About

Sara E. Kost is a scholar working on Genetics, Immunology and Oncology. According to data from OpenAlex, Sara E. Kost has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Immunology and 4 papers in Oncology. Recurrent topics in Sara E. Kost's work include Chronic Lymphocytic Leukemia Research (6 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Sara E. Kost is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Sara E. Kost collaborates with scholars based in Canada, China and United States. Sara E. Kost's co-authors include Brad H. Nelson, Ronald J. deLeeuw, Juzer Kakal, Katy Milne, Peter H. Watson, Julie S. Nielsen, Rob A. Sahota, Nancy J. Nesslinger, Nathaniel R. West and Spencer D. Martin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Cancer Research.

In The Last Decade

Sara E. Kost

14 papers receiving 1.1k citations

Peers

Sara E. Kost

ONCOL

IMMUN

PRM

Annechien Plat Netherlands

Hans-Jürgen Gober China

Amelia J. Tesone United States

A. Nazmul H. Khan United States

Hiroyoshi Hattori Japan

Rebecca Kesselring Germany

Yann Godet France

Ana Vuletić Serbia

Devin B. Lowe United States

Annechien Plat Netherlands

Sara E. Kost

544 ×0.7

ONCOL

538 ×0.7

IMMUN

286 ×1.6

88 ×0.9

67 ×0.8

PRM

Citations per year, relative to Sara E. Kost Sara E. Kost (= 1×) peers Annechien Plat

Countries citing papers authored by Sara E. Kost

Since Specialization

Citations

This map shows the geographic impact of Sara E. Kost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara E. Kost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara E. Kost more than expected).

Fields of papers citing papers by Sara E. Kost

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara E. Kost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara E. Kost. The network helps show where Sara E. Kost may publish in the future.

Co-authorship network of co-authors of Sara E. Kost

This figure shows the co-authorship network connecting the top 25 collaborators of Sara E. Kost. A scholar is included among the top collaborators of Sara E. Kost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara E. Kost. Sara E. Kost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Chen, Yongqiang, Sara E. Kost, Xiaoyan Yang, et al.. (2023). Venetoclax inhibits autophagy in chronic lymphocytic leukemia cells. SHILAP Revista de lepidopterología. 2(1). 2169518–2169518. 2 indexed citations

Ishdorj, Ganchimeg, Zoann Nugent, Sara E. Kost, et al.. (2021). Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines. Leukemia Research. 109. 106628–106628. 3 indexed citations

Kost, Sara E., Ali Saleh, Edgard M. Mejia, et al.. (2019). Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia. Cancers. 11(10). 1519–1519. 3 indexed citations

Ishdorj, Ganchimeg, et al.. (2017). A novel spliced variant of the TIN2 shelterin is present in chronic lymphocytic leukemia. Leukemia Research. 59. 66–74. 3 indexed citations

Kost, Sara E., Xibiao Ye, Versha Banerji, et al.. (2016). Cross-resistance and synergy with bendamustine in chronic lymphocytic leukemia. Leukemia Research. 50. 63–71. 7 indexed citations

Zhang, Yunli, Sara E. Kost, Robert A. Schmidt, et al.. (2016). High Cumulative Illness Rating Scale (CIRS) Score in CLL Correlates with Short CLL Telomere Length and Decreased Survival. Blood. 128(22). 4362–4362. 1 indexed citations

Khan, Deirdre, Ian J. Girard, Ryan C. Kirkbride, et al.. (2015). Transcriptome atlas of the Arabidopsis funiculus – a study of maternal seed subregions. The Plant Journal. 82(1). 41–53. 31 indexed citations

deLeeuw, Ronald J., David R. Kroeger, Sara E. Kost, et al.. (2014). CD25 Identifies a Subset of CD4+FoxP3− TIL That Are Exhausted Yet Prognostically Favorable in Human Ovarian Cancer. Cancer Immunology Research. 3(3). 245–253. 36 indexed citations

Nielsen, Julie S., Rob A. Sahota, Katy Milne, et al.. (2012). CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer. Clinical Cancer Research. 18(12). 3281–3292. 418 indexed citations

10.

deLeeuw, Ronald J., Sara E. Kost, Juzer Kakal, & Brad H. Nelson. (2012). The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature. Clinical Cancer Research. 18(11). 3022–3029. 368 indexed citations

11.

West, Nathaniel R., Sara E. Kost, Spencer D. Martin, et al.. (2012). Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer. British Journal of Cancer. 108(1). 155–162. 205 indexed citations

12.

Kost, Sara E., Chao Sun, Wei Xiong, et al.. (2011). Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice. Behavioural Brain Research. 224(1). 44–49. 7 indexed citations

13.

Nichol, Kimberly A., Heather J. Adam, Zafar Hussain, et al.. (2011). Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007–2009 study. Diagnostic Microbiology and Infectious Disease. 69(3). 320–325. 56 indexed citations

14.

Mataseje, Laura, Jerry Xiao, Sara E. Kost, et al.. (2009). Characterization of Canadian cefoxitin-resistant non-typhoidal Salmonella isolates, 2005-06. Journal of Antimicrobial Chemotherapy. 64(4). 723–730. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact